Additionally, CXCR4, the receptor for CXCL12, is overexpressed on CLL cells compared to normal B cells, and thus has the potential for enhanced responsiveness to CXCL12 signaling [5]. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.